Low-Dose Lenalidomide After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation With Bortezomib as Graft-Versus-Host Disease Prophylaxis in High-Risk Multiple Myeloma.

Details

Language :

English

ISSN :

21522650

Volume :

19

Issue :

7

Database :

Complementary Index

Journal :

Clinical Lymphoma, Myeloma & Leukemia

Publication Type :

Academic Journal

Accession number :

137372890

Full Text :

https://doi.org/10.1016/j.clml.2019.03.019